Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q71774511)
Watch
English
Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S)
scientific article published on 01 September 1995
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7572690
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572690%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 October 2019
title
Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S)
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7572690
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572690%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 October 2019
main subject
simvastatin
1 reference
based on heuristic
inferred from title
author
John Kjekshus
series ordinal
1
object named as
J Kjekshus
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7572690
retrieved
21 October 2019
author name string
T R Pedersen
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7572690
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572690%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 October 2019
language of work or name
English
0 references
publication date
1 September 1995
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7572690
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572690%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 October 2019
published in
American Journal of Cardiology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7572690
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572690%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 October 2019
volume
76
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7572690
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572690%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 October 2019
issue
9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7572690
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572690%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 October 2019
page(s)
64C-68C
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7572690
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572690%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 October 2019
cites work
Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980473-1
retrieved
7 January 2021
The value of lowering cholesterol after myocardial infarction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980473-1
retrieved
7 January 2021
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980473-1
retrieved
7 January 2021
Cholesterol reduction yields clinical benefit. A new look at old data
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980473-1
retrieved
7 January 2021
Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980473-1
retrieved
7 January 2021
Misleading meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980473-1
retrieved
7 January 2021
Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980473-1
retrieved
7 January 2021
Doubts about preventing coronary heart disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980473-1
retrieved
7 January 2021
Should there be a moratorium on the use of cholesterol lowering drugs?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980473-1
retrieved
7 January 2021
Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980473-1
retrieved
7 January 2021
An updated coronary risk profile. A statement for health professionals.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980473-1
retrieved
7 January 2021
The oxidation hypothesis of atherosclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980473-1
retrieved
7 January 2021
Lower patients' cholesterol now
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980473-1
retrieved
7 January 2021
Cholesterol lowering does have a role in secondary prevention
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2980473-1
retrieved
7 January 2021
Identifiers
DOI
10.1016/S0002-9149(99)80473-1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7572690
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572690%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 October 2019
PubMed publication ID
7572690
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7572690
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7572690%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 October 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit